TL;DR: Delineate is a Y Combinator Winter 2025 startup Agents for Accelerated Clinical Trial Design, currently active with a team of 20.
Agents for Accelerated Clinical Trial Design
Last verified:
Delineate is building AI agents to design better clinical trials faster. This is a $10B dollar market, where saving even 1 day along the process is equal to $1-5M in revenue potential. We process existing clinical trial research into specialized datasets saving scientists months of effort. Delineate is working with two of the largest pharmaceutical companies. With one of our customers, we are helping them get to the next phase of trials faster by creating the largest dataset on a drug class ever constructed.
Built by LemStudio
Yes. Delineate was funded by Y Combinator in the Winter 2025 batch. Agents for Accelerated Clinical Trial Design
Delineate is building AI agents to design better clinical trials faster. This is a $10B dollar market, where saving even 1 day along the process is equal to $1-5M in revenue potential. We process existing clinical trial research into specialized datasets saving scientists months of effort. Delineate is working with tw…
Delineate was part of Y Combinator's Winter 2025 batch.
Delineate has a team of 20 people according to Y Combinator's directory.
Delineate is currently listed as Active with a team of 20 in Y Combinator's directory.
Loading interactive view…